Publication | Closed Access

Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers

UrologyOncologyMdr1 PolymorphismsGenitourinary CancerMedicinePharmacotherapyAnti-cancer AgentCancer TreatmentUrogenital CancersPharmacology